BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  SciMount announces FDA approval of SMP-100’s IND application for the treatment of Irritable Bowel Syndrome

  SciMount Pharmatech, Co. Ltd., a wholly-owned subsidiary of Xiling Lab, announces that the U.S. Food and Drug Administration has approved the Investigational New Drug application for SMP-100 for the treatment of Irritable Bowel Syndrome with diarrhea.

  May 14, 2020

   · 

  2 min read
• Hyperhidrosis Treatment Market: Adoption of Microwave Technology & Botulinum Toxin to Reach New Heights

  Transparency Market Research has published a new report on the global hyperhidrosis treatment market for the forecast period of 2019–2027.

  May 14, 2020

   · 

  5 min read
• Platelet Rich Plasma Market - Technological Advances Study

  Plasma refers to the liquid portion of one’s blood, in which vitamins, white and red blood cells, and salts are found.

  May 14, 2020

   · 

  3 min read
• Fish Collagen Peptides Market: Cosmetic and Pharmaceutical Potential of Fish Collagen Peptides Foster Innovation

  Transparency Market Research has published a new report on the fish collagen peptides market for the forecast period of 2019–2027.

  May 14, 2020

   · 

  5 min read
• Herpes Simplex Virus (HSV) Vaccines Market Detailed Study Analysis and Forecast by 2028

  Herpes simplex virus vaccines help preventing the occurrence of herpes disease.

  May 14, 2020

   · 

  4 min read
• 3D Cell Culture Market – Current Scenario of Industry with Future Growth Analysis Report

  The 3D cell culture market is seeing a steady development because of the elements, as tremendous ventures by life science organizations for R&D, advancement of robotized enormous scale cell culture frameworks, and rising requirement for organ replacement.

  May 14, 2020

   · 

  4 min read
• Drug Development

  RegeneRx Joint Venture Announces Efficacy Results of Neurotrophic Keratopathy Phase 3 Clinical Trial with RGN-259

  RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration announced efficacy results of its Phase 3 clinical trial in patients with neurotrophic keratopathy.

  May 14, 2020

   · 

  7 min read